Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 589

1.

Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.

Kalkanci A, Yesilirmak N, Ozdemir HB, Unal EA, Erdoğan M, Seker T, Tum AE, Karakus AK, Hizel K, Bilgihan K.

Cornea. 2018 Nov;37(11):1463-1467. doi: 10.1097/ICO.0000000000001696.

PMID:
30161054
2.

What is an appropriate dose of voriconazole for the treatment of aspergillosis in African grey parrots (Psittacus erithacus)?

O'Connor L, Reyher K, Place E, Abou-Zahr T.

Vet Rec. 2018 Jul 28;183(4):131-132. doi: 10.1136/vr.k3154. No abstract available.

PMID:
30054411
3.

A rare case of Lecythophora endogenous endophthalmitis: Diagnostic and therapeutic challenge.

Dogra M, Dhingra D, Sharma SP, Bansal R.

Indian J Ophthalmol. 2018 Aug;66(8):1203-1205. doi: 10.4103/ijo.IJO_181_18.

4.

Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics.

Al-Ghobashy MA, Kamal SM, El-Sayed GM, Attia AK, Nagy M, ElZeiny A, Elrakaiby MT, Nooh MM, Abbassi M, Aziz RK.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:489-498. doi: 10.1016/j.jchromb.2018.06.043. Epub 2018 Jun 27.

PMID:
30008305
5.

Biguanides enhance antifungal activity against Candida glabrata.

Xu S, Feliu M, Lord AK, Lukason DP, Negoro PE, Khan NS, Dagher Z, Feldman MB, Reedy JL, Steiger SN, Tam JM, Soukas AA, Sykes DB, Mansour MK.

Virulence. 2018;9(1):1150-1162. doi: 10.1080/21505594.2018.1475798.

6.

Management of Candida glabrata infectious crystalline keratopathy with endophthalmitis following penetrating keratoplasty.

Nagpal R, Chaurasia S, Joseph J, Tyagi M, Rani PK, Ramappa M, Shah R.

Indian J Ophthalmol. 2018 Jul;66(7):1012-1014. doi: 10.4103/ijo.IJO_1106_17.

7.

The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers.

Santos GA, Angelo T, Andrade LM, Silva SMM, Magalhães PO, Cunha-Filho M, Gelfuso GM, Taveira SF, Gratieri T.

Colloids Surf B Biointerfaces. 2018 Oct 1;170:341-346. doi: 10.1016/j.colsurfb.2018.06.037. Epub 2018 Jun 19.

PMID:
29940500
8.

Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child-Pugh class B and C cirrhosis: A multicenter study.

Wang T, Yan M, Tang D, Xue L, Zhang T, Dong Y, Zhu L, Wang X, Dong Y.

Int J Infect Dis. 2018 Jul;72:49-54. doi: 10.1016/j.ijid.2018.05.009. Epub 2018 May 21.

9.

Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.

Gunaratne K, Austin E, Wu PE.

BMC Res Notes. 2018 May 21;11(1):331. doi: 10.1186/s13104-018-3404-8.

10.

Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.

Singh R, Kumari A, Kaur K, Sethi P, Chakrabarti A.

J Med Microbiol. 2018 Jul;67(7):922-926. doi: 10.1099/jmm.0.000757. Epub 2018 May 16.

PMID:
29767615
11.

Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child-Pugh Class C).

Yamada T, Imai S, Koshizuka Y, Tazawa Y, Kagami K, Tomiyama N, Sugawara R, Yamagami A, Shimamura T, Iseki K.

Biol Pharm Bull. 2018 Jul 1;41(7):1112-1118. doi: 10.1248/bpb.b18-00164. Epub 2018 May 11.

12.

Massive haemoptysis secondary to mycotic pulmonary artery aneurysm in subacute invasive aspergillosis.

Piracha S, Mahmood A, Qayyum N, Ganaie MB.

BMJ Case Rep. 2018 Apr 19;2018. pii: bcr-2017-223088. doi: 10.1136/bcr-2017-223088.

PMID:
29674397
13.

[Therapeutic monitoring of antimicrobial agents in pediatrics. Review based on Latin American experiences].

Zylbersztajn B, Barraza M, Torres JP, Morales J.

Rev Chilena Infectol. 2018;35(1):22-28. doi: 10.4067/s0716-10182018000100022. Review. Spanish.

14.

Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.

Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW.

PLoS One. 2018 Apr 10;13(4):e0193732. doi: 10.1371/journal.pone.0193732. eCollection 2018.

15.

Macular toxicity and blind spot enlargement during a treatment by voriconazole: A case report.

Mounier A, Agard E, Douma I, Chehab HE, Vie AL, Dot JM, Dot C.

Eur J Ophthalmol. 2018 Jul;28(4):NP11-NP14. doi: 10.1177/1120672117750051. Epub 2018 Apr 6.

PMID:
29623723
16.

In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.

Fakhim H, Vaezi A, Dannaoui E, Sharma C, Mousavi B, Chowdhary A, Meis JF, Badali H.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):266-268. doi: 10.1016/j.diagmicrobio.2018.03.003. Epub 2018 Mar 8.

PMID:
29622284
17.

A robust LC-MS/MS method for the simultaneous determination of docetaxel and voriconazole in rat plasma and its application to pharmacokinetic studies.

Pei X, Li P, Jiang W, Sun Y, Lu L, Ding F, Wang G, Hao K.

Biomed Chromatogr. 2018 Aug;32(8):e4246. doi: 10.1002/bmc.4246. Epub 2018 May 10.

PMID:
29574985
18.

Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.

Imataki O, Yamaguchi K, Uemura M, Fukuoka N.

Transpl Infect Dis. 2018 Aug;20(4):e12886. doi: 10.1111/tid.12886. Epub 2018 Apr 10.

PMID:
29570914
19.

A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment.

Li AW, Lalor LE, Bellodi Schmidt F, Luu M.

Pediatr Dermatol. 2018 May;35(3):e165-e169. doi: 10.1111/pde.13473. Epub 2018 Mar 23.

PMID:
29570823
20.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767

Supplemental Content

Loading ...
Support Center